HealthCap, Versant et al. lead SEK 437m series-B for Aprea
Swedish biotech company Aprea has raised a SEK 437m series-B led by Versant Ventures, 5AM Ventures and Healthcap, alongside additional capital providers.
More on Early-stage
Gyroscope Therapeutics raises $148m in Forbion-led series C
Series-C round for the gene therapy company is led by Forbion’s Growth Opportunities Fund
OpenOcean and Spintop lead €3.6m series-A for Cambri
Lynda Clarizio, former president of Nielsen US Media, joins the board of directors
ByFounders leads $4.6m seed round for Proper
Other investors include PreSeed Ventures, Prehype, Vaekstfonden and Bjarke Ingels
Claris Ventures leads £15.2m series-B for NeoPhore
2Invest, 3B Future Health Fund, Astellas Venture Management and CRT Pioneer Fund also take part in the round
Latest News
Altor sells Centralpoint to trade for €425m
GP intends to acquire a stake in acquirer Dustin, which Altor listed in 2015
Gro Capital invests in Danish firm Luxion
According to Borsen, the GP's stake is more than 35% and that the deal valued Luxion at almost DKK 1bn (€134.5m)
Phoenix launches £100m venture capital fund
Fund enables Phoenix to build portfolios with exposure to venture capital investments for its policyholders
Strong 2020 for Nordic tech, VC and IPOs, says Argentum
Despite the pandemic, 2020 was one of the best years for venture capital, tech companies in both buyout and VC markets, and established GPs who raised record-breaking amounts, according to Argentum's 2020 State of Nordic Private Equity report. Joachim...